In the present study we determined the resistance patterns of anaerobic bacteria from human saliva and stool specimens and investigated whether there were significant differences in resistance between outpatients and hospitalized patients, regardless of whether they had received antimicrobial agents. No bacterial strains resistant to ampicillin, piperacillin, cefoxitin, cefuroxime, imipenem, clindamycin, doxycycline, chloramphenicol, or metronidazole were isolated from the saliva samples. However, resistance to ampicillin, cefoxitin, and cefuroxime was found in strains from 70%o of the fecal samples (mainly Bacteroides thetaiotaomicron, Clostridium innocuum, and Bacteroides ovatus). Resistance to both ampicillin and cefuroxime was frequently found in 19%o of the isolated strains (mainly B. thetaiotaomicron, B. ovatus, and Bacteroides vulgatus). No strains that were resistant to imipenem, chloramphenicol, or metronidazole were found. Hospitalization and/or intake of antimicrobial agents was associated with an increase in the relative number of resistant anaerobic intestinal bacteria. The percentage of resistant anaerobic strains encountered, compared with the total number of anaerobic bacteria in the normal fecal microflora, was between 5.2 and 14.8%, with the lower value associated with the outpatient group. Two-thirds of the resistant strains from this group had a relative frequency of less than 1% of the total anaerobic flora, while one-third of the strains were present at a level of greater than 1%; for the hospitalized patients, two-thirds of the strains were present at a level of greater than 1%, and one-third of the strains were present at a level of less than 1% (P < 0.001). Patients who had received antimicrobial agents for 6 days or more (n = 20) had an average of 1.6 resistant anaerobic strains each, while patients treated for 3 to 5 days (n = 30) had a mean number of 0.87 resistant strains each (P < 0.05).
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The normal human oral and intestinal microfloras are huge potential reservoirs of resistant organisms which may cause infections in other sites of the body. Bacteria from the intestinal microflora dominate as causative agents in postoperative infections, and resistance among them may seriously complicate the prophylaxis and treatment of intra-abdominal infections (12) .
A correlation between drug consumption and the emergence of bacterial drug resistance in the normal intestinal microflora of outpatients and hospitalized patients has been reported (1, 6, 8, 19) . Those investigations have mainly focused on aerobic bacteria; it has been shown that administration of ampicillin or tetracycline significantly increases the number of resistant gram-negative aerobic microorganisms in the fecal flora, while other agents such as amoxicillin, cefuroxime, imipenem, and metronidazole have been shown to have no impact on the development of resistance patterns (12, 18) .
Most of the anaerobic microorganisms that cause clinical infections come from the normal oropharyngeal and gastrointestinal microfloras. Since anaerobic bacteria outnumber the aerobic bacteria both in the oral cavity (100:1) and in the intestinal tract (1,000:1), it is of interest to investigate the antimicrobial resistance patterns in the normal anaerobic microfloras from both outpatient and hospitalized individuals.
The aim of the present study was to investigate the resistance patterns in the normal oral and intestinal microfloras of outpatients with no recent history of antimicrobial * Corresponding author. treatment compared with those in the microfloras of hospitalized patients with and without a recent history of antimicrobial treatment. An the center of the sample and was mixed in 4.5 ml of prereduced PYG. From this solution, 0.5 ml was further suspended in 4.5 ml of PYG. From the bacterial suspension thus obtained, samples of 0.1 ml were rapidly applied onto each of nine PDM agar plates with different antimicrobial agents and gentamicin as described earlier and on two control plates, aerobic and anaerobic, and after further dilution (1:100), a second anaerobic control plate was also included. Microbiological analysis. After incubation in anaerobic jars (GasPak) at 37°C for 48 h, the total number of anaerobic colonies growing on each control plate was counted. The resistant microorganisms growing on the antimicrobial plates were enumerated, isolated in pure cultures, and identified by morphological, gas chromatographic, and biochemical tests (14) . As a control, all strains isolated were also incubated aerobically, and the strains which grew were disregarded. Impact of antimicrobial treatment. The majority of patients in group C were treated with cefuroxime (36 patients). These patients were not specifically predisposed to an increase in the number of bacteria resistant to cefuroxime or to any beta-lactam agent in general. Neither was any statistically significant correlation found between patients receiving beta-lactam agents and the occurrence of beta-lactam resistance. Four of six patients receiving antimicrobial agents not belonging to the beta-lactam group harbored resistant strains. For 20 patients who were treated with antimicrobial agents for 6 days or more, 9.9% of the anaerobic fecal microfloras of these patients were resistant to the antimicrobial agents tested, while for 30 patients who received anti- Patients treated for 6 days or more had an average of 1.6 resistant strains each, while patients treated for less than 6 days had a mean number of 0.87 resistant strains each (P < 0.05).
DISCUSSION
Anaerobic infections often originate from microorganisms from the patient's own microflora, and many antimicrobial agents that are active against these organisms are now available. However, an increasing number of treatment failures caused by anaerobic oacteria that are resistant to antimicrobial agents have been reported (3, 15) . The results of the present study show that the frequency of resistant anaerobic microorganisms in the oropharyngeal tract is low in Sweden. This is in accordance with a study by Heimdahl et al. (10) , who investigated the occurrence of 1-lactamaseproducing Bacteroides species in the oral cavity in relation to penicillin therapy. Only a few beta-lactam-resistant Bacteroides strains were isolated from saliva samples in that study, and most patients harboring resistant strains had recently been treated with penicillin or ampicillin. The breakpoints of penicillin and ampicillin used in that study were . 4 ,ug/ml; compare this with a breakpoint of 232 ,ug/ml for ampicillin in the present study. Bacteroides species are the most common pathogens in oral infections, and most strains are susceptible to clindamycin, metronidazole, and chloramphenicol (4, 10, 11) .
In the current study, the prevalence of patients with resistant anaerobic strains in their intestinal tracts was high (70%), with no significant difference between the three patient groups. The results of the present study show that although outpatients seem to have a higher number of resistant strains per person, the relative amount of resistant anaerobic bacteria in feces is lower in outpatients compared with that in hospitalized patients. In the outpatient group, one-third of the resistant strains made up more than 1% of the total anaerobic microflora, while in both hospitalized groups, two-thirds of the resistant strains constituted more than 1% of the total anaerobic fecal flora. Strains from the B. fragilis group were isolated most frequently, as has been reported previously (1, 3, 12) . B. thetaiotaomicron and B. ovatus were the most commonly isolated members of the B. fragilis group. In previous studies, B. ovatus and then B. fragilis were the most frequently isolated anaerobic resistant strains from intestinal microfloras (1, 12) . The antimicrobial susceptibility of the B. fragilis group in the present study correlates well with those found in recent investigations in Canada and Europe (12, 16) .
The known mechanisms of resistance to beta-lactam antibiotics in anaerobic bacteria are elaboration of ,3-lactamases, which inactivate the agent; alteration of the number or type of penicillin-binding proteins, which affects the affinity of the proteins for the antibiotics; and blocked penetration of the agent into the active site via alteration of the bacterial outer membrane porins (7, 20) . The most important factor in beta-lactam resistance appears to be the production of P-lactamases, which have been found in various Bacte- roides, Fusobacterium, and Clostndium species (15 The increased use of cefuroxime and metronidazole has not been correlated with the emergence of drug-resistant aerobic or anaerobic intestinal bacteria (12, 13) . Since the most common drug regimen in the present study was cefuroxime, which was often used in combination with metronidazole, it is not surprising that no major differences between the hospitalized patient groups were found. However, patients who had antimicrobial treatment for 6 days or more had a significantly increased number of resistant anaerobic strains in their fecal microfloras compared with the numbers in patients who were treated for shorter periods of time.
Patients who had been treated in the hospital for at least 6 days (groups B and C) had a significantly higher relative number of resistant microorganisms in their anaerobic intestinal microfloras compared with the numbers in outpatients. These results correlate well with those from the study by Levy et al. (13) (8, 21) .
In conclusion, the anaerobic intestinal microflora contains a large number of resistant anaerobic bacteria that mainly belong to the B. fragilis group. It seems that hospitalization or intake of antimicrobial agents promotes an increase in the relative number of resistant anaerobic microorganisms isolated from feces.
